FdaApplication
ANDA 211065
Identifiers
- fda_app_no: ANDA211065
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2022-10-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET;ORAL |
1 product